• COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION

This section hosts guidelines, manuals and toolkits to strengthen public health practice.

Resources

FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E

EXPLORE DATA
VISUALIZATIONS

Explore key data on health and its determinants in India through interactive graphs.

Strategies comparison in response to the two waves of COVID-19 in the United States and India

23 May 2022
Emerging Pandemics

by Junyan Yang, et al. 20

This study aims to evaluate and analyze the effectiveness of the prevention and control techniques used by the United States and India during the COVID-19 outbreak in order to give empirical experience for epidemic prevention and control. To combat the two waves of the epidemic, the US implemented a number of mitigation methods, including improving virus detection, requiring individuals to wear masks, and so on. Meanwhile, India had implemented containment tactics throughout the early stages of the outbreak, resulting in a rather stable epidemic. India has shifted its focus to mitigation methods in the latter stages. Furthermore, a number of variables, including a shortage of medical resources and premature relaxation measures, contributed to the epidemic's quick progression. There are distinctions between the United States' and India's epidemic prevention efforts, particularly India's containment strategies, which helped it better, control the epidemic early on. The outbreak, however, continues to be severe in both countries. With the emergence of virus mutants and the lack of immune barriers, it is critical that the two countries continue to use non-pharmacotherapy intervention measures and accelerate vaccination, adopt containment strategies that can control the epidemic more quickly when necessary, and pay attention to the risk of epidemic rebound caused by premature relaxation of epidemic prevention policies, according to specific national circumstances.

To read the full article, please download the linked file.

Related File :

275590703.pdf

Categories

COVID-19
KEY ORGANIZATIONS
Connect with Us
Subscribe to the Newsletter

FOLLOW US

  • HOME
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
  • LEARNING LIBRARY
  • DATA VISUALIZATION
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2025 Swasti Health Catalyst

Subscribe to the Newsletter

Submit Feedback

  • COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION